相关实验视频
Updated: Jun 28, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
瘤基因诱导的矩阵重组控制了软组织肉瘤微环境中的CD8+T细胞功能
Ashley M Fuller1, Hawley C Pruitt2, Ying Liu1
1Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Penn Sarcoma Program, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
The Journal of clinical investigation
|April 23, 2024
概括
转录协激活剂YAP1驱动着原VI沉积,损害了肉瘤中CD8+T细胞的功能. 原I可以抵消这种作用,通过支持T细胞功能来促进抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- CD8+ T 细胞功能障碍限制了固体瘤中的抗瘤免疫力.
- 瘤微环境的细胞外基质 (ECM) 影响T细胞功能,但具体的分子影响尚不清楚.
- 在瘤中失调的ECM沉积缺乏明确的上游调节器.
研究的目的:
- 为了研究ECM组成如何影响CD8+ T细胞功能在不分化的多形肉 Sarcoma (UPS).
- 在UPS瘤微环境 (TME) 中识别ECM沉积的上游调节者.
主要方法:
- 使用了UPS的土著小鼠模型.
- 分析了来自多个人类患者队伍的数据.
- 研究了YAP1,原VI (COLVI) 和原I (COLI) 在UPS TME中的作用.
主要成果:
- YAP1促进了UPS TME中的COLVI沉积.
- 科尔维通过重塑原蛋白和损害T细胞自流来抑制CD8+T细胞功能,促进免疫逃避.
- COLI 抵消了 COLVI 的作用,增强了 CD8+ T 细胞功能,并作为瘤抑制剂.
结论:
- 瘤CD8+T细胞的反应严重依赖于瘤基因驱动的ECM组成和重塑.
- 通过YAP1介导的COLVI沉积是UPS中免疫逃避的一个关键机制.
- 针对ECM组成,特别是COLVI和COLI的平衡,可能是增强抗瘤免疫力的治疗策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K

